Xtant Medical Holdings Inc
General ticker "XTNT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $51.9M
Xtant Medical Holdings Inc does not follow the US Stock Market performance with the rate: -35.0%.
Estimated limits based on current volatility of 5.4%: low 0.35$, high 0.39$
Factors to consider:
- US accounted for 98.6% of revenue in the fiscal year ended 2022-12-31
- Current price 37.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.65$, 1.69$]
- 2024-12-30 to 2025-12-30 estimated range: [0.58$, 1.53$]
Financial Metrics affecting the XTNT estimates:
- Negative: Non-GAAP EPS, $ of 0 <= 0.10
- Negative: Operating profit margin, % of -10.01 <= 1.03
- Negative: Operating cash flow per share per price, % of -6.06 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.21
- Positive: Interest expense per share, $ of 0.02 <= 0.14
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 0.71
Short-term XTNT quotes
Long-term XTNT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $55.26MM | $57.97MM | $91.30MM |
| Operating Expenses | $59.12MM | $64.72MM | $101.46MM |
| Operating Income | $-3.85MM | $-6.75MM | $-10.16MM |
| Non-Operating Income | $-0.99MM | $-1.66MM | $9.12MM |
| Interest Expense | $0.99MM | $1.69MM | $2.94MM |
| R&D Expense | $0.87MM | $0.92MM | $1.34MM |
| Income(Loss) | $-4.85MM | $-8.42MM | $-1.04MM |
| Taxes | $0.99MM | $0.07MM | $-1.70MM |
| Profit(Loss) | $-5.84MM | $-8.48MM | $0.66MM |
| Stockholders Equity | $30.88MM | $34.17MM | $51.35MM |
| Inventory | $17.95MM | $17.29MM | $36.88MM |
| Assets | $54.69MM | $60.23MM | $92.61MM |
| Operating Cash Flow | $0.44MM | $-5.34MM | $-9.52MM |
| Capital expenditure | $2.12MM | $1.76MM | $1.46MM |
| Investing Cash Flow | $-1.89MM | $-1.56MM | $-24.78MM |
| Financing Cash Flow | $17.50MM | $9.02MM | $19.69MM |
| Earnings Per Share* | $-0.07 | $-0.09 | $0.01 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.